Novartis India open offer: Zero shares tendered in demat as of June 22

Listed Co AcquisitionOpen Offer TriggeredStrategic Transactions View source PDF Explain this filing

NOVARTIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹1510.10

prior close

₹1513.60

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.7%-1.2% vs market

Pharmaceuticals peers, median of 165sector+0.4%-2.3% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 2.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.8

10m

+0.6

15m

-0.9

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.9-0.7-1.2+0.4-2.3

Next day

-2.3-0.8-1.5+0.6-3.0

-5.2-1.4-3.8+0.2-5.4

-4.3-1.7-2.6+0.2-4.5

-5.3-0.7-4.6+1.3-6.6

-4.0-0.5-3.5+1.2-5.2

-2.7+0.0-2.8+2.0-4.8

15d

+4.0+0.5+3.5+3.3+0.6

+11.7-1.9+13.6+0.7+10.9

-1.3+4.3-5.6+1.7-3.0

+34.6+5.8+28.7+5.1+29.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Axis Capital, manager to Novartis India open offer, disclosed that as of June 22, 2026, NIL shares were tendered in demat form and 10 shares in physical form, together about 0.00 percent of the offer size of 64,19,608 shares. The offer is for 26 percent of voting capital from public shareholders, by WaveRise Investments, ChrysCapital, and Two Infinity Partners.

Likely market impact

Very low shareholder response so far; final acceptance depends on offer price versus market price.